Drug Profile
Research programme: prostaglandin analogues - Alcon
Alternative Names: AL-12182; Prostaglandin analogues research programme - AlconLatest Information Update: 15 Apr 2019
Price :
$50
*
At a glance
- Originator Alcon
- Class
- Mechanism of Action Prostaglandin agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Glaucoma
Most Recent Events
- 09 Apr 2019 Novartis completed the spin-off of Alcon
- 02 Jul 2007 Discontinued - Preclinical for Glaucoma in USA (unspecified route)
- 06 Sep 2004 Preclinical trials in Glaucoma in USA (unspecified route)